L. Inhibiteurs-de-la-neuraminidase and .. , 65 III. Les épizooties de peste aviaire en France et en, p.70

.. Exemple-de-la-moselle, Prise en charge d'un foyer de peste aviaire, p.74

L. Différents-types-de-réseaux and .. , 90 a) Les réseaux de laboratoire 90 b) Les réseaux de surveillance en population, p.90

. Hong-kong, Dix-huit personnes sont infectées, il y aura six décès. Mais la maladie est contenue après l'extermination des poulets contaminés 6

. En-août-de-la-même-année, Kazakhstan et en Mongolie que l'on retrouve le virus. Le même mois, il fait sa première apparition européenne en Russie

À. De-février and . Mai, Allemagne a connu un grand nombre de cas dans la faune sauvage, 2006.

. Durant-le-mois-de-février, de nombreux oiseaux sauvages ont été retrouvés morts sur l'île de Rügen. Il s'agissait de cygnes mais également de canards et d'oies

. En-février, quatorze pays déclarent un foyer initial chez les oiseaux sauvages, 2006.

L. Montenegro, . Pologne, . Le-danemark, . Le-nigeria, L. La-suède et al., la République tchèque, toujours chez les oiseaux sauvages. Le même mois, le Pakistan, l'Albanie, le Cameroun, la Suède, l'Israël, l'Afghanistan, la Jordanie déclarent le virus au sein des volailles d'élevage

. Sur-la-période, soixante et un pays ont déclaré l'influenza aviaire hautement pathogène à virus H5N1 chez des volailles d'élevage ou des oiseaux sauvages. Nous nous apercevons que le continent américain et l'Océanie sont indemnes. 2. Chez l'homme BIBLIOGRAPHIE, 2003.

C. F. Heusinger, Recherches de pathologie comparée, Eds Cassel chez H. Hotop, 1853.

C. F. Heusinger, Recherches de pathologie comparée, Eds Cassel chez H. Hotop, 1853.

G. Fleming, Animal plagues : their history, nature and prevention, 1821.
DOI : 10.5962/bhl.title.100003

J. Blancou, Histoire de la surveillance et du contrôle des maladies animales transmissibles. Eds Office international des épizooties, 2000.

C. Pasquier, S. Bertagnoli, F. Messud-petit, and J. Izopet, Les virus à ARN : famille des Orthomyxoviridae, Virologie humaine et animale, cours, fiches de synthèse et QCM, pp.212-215, 2005.

C. Hannun, P. Léophonte, and D. Peyramond, La grippe, Annales de l'Institut Pasteur / Actualit??s, vol.6, issue.1, 2003.
DOI : 10.1016/0924-4204(96)83604-3

N. Naffakh and S. Van-der-werf, Orthomyxoviridae In: Traité de virologie médicale Eds Huraux, pp.439-457, 2003.

H. D. Klenk, Orthomyxoviridés In : Classification et nomenclature des virus ., 5 ème rapport du Comité International de Taxonomie des Virus, pp.253-261, 1994.

G. Meulemans, Infections à Orthomyxoviridus, pp.107-112, 1992.

S. Van-der-werf, Structure et variation des virus grippaux In : Grippe et infections virales des voies aériennes supérieures, tome 1, Guides Médi, p.51, 2001.

R. A. Fouchier, V. Munster, A. Wallensen, T. M. Bestebroer, S. Herfst et al., Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls, Journal of Virology, vol.79, issue.5, pp.2814-2822, 2005.
DOI : 10.1128/JVI.79.5.2814-2822.2005

J. P. Derenne and F. Bricaire, Pandémie : la grande menace. Grippe aviaire : 500000 morts en France ? Eds Fayard, 2005.

C. R. Parrish and Y. Kawaoka, THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses, Annual Review of Microbiology, vol.59, issue.1, pp.553-586, 2005.
DOI : 10.1146/annurev.micro.59.030804.121059

C. Saegerman, G. Meulemans, K. Van-reeth, D. Marlier, F. Yane et al., Evaluation, contrôle et prévention du risque de transmission du virus influenza aviaire à l'homme, Ann. Med. Vét, vol.148, pp.65-77, 2004.

G. N. Rogers and J. C. Paulson, Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin, Virology, vol.127, issue.2, pp.361-373, 1983.
DOI : 10.1016/0042-6822(83)90150-2

S. J. Baigent and J. W. Mccauley, Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission, BioEssays, vol.176, issue.7, pp.657-671, 2003.
DOI : 10.1086/514177

Y. Suzuki, Host Mediated Variation and Receptor Binding Specificity of Influenza Viruses, Adv Exp Med Biol, vol.491, pp.445-451, 2001.
DOI : 10.1007/978-1-4615-1267-7_29

Y. Suzuki, Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses, Biological and Pharmaceutical Bulletin, vol.28, issue.3, pp.399-408, 2005.
DOI : 10.1248/bpb.28.399

F. Freymuth, Orthomyxoviridae: les virus influenza, Presses universitaires de Lyon, pp.407-420, 2002.

K. G. Nicholson, R. G. Webster, and A. Hay, Textbook of Influenza, 1998.

R. A. Lamb and R. M. Krug, Orthomyxoviridae : the viruses and their replication, 2001.

P. Benedictis, Inactivation of Avian Influenza Viruses by Chemical Agents and Physical Conditions: A Review, Zoonoses and Public Health, vol.68, issue.Suppl. 3, pp.51-68, 2007.
DOI : 10.3201/eid1004.030396

E. A. Govorkova, J. E. Rehg, S. Krauss, H. L. Yen, Y. Guan et al., Lethality to Ferrets of H5N1 Influenza Viruses Isolated from Humans and Poultry in 2004, Journal of Virology, vol.79, issue.4, pp.2191-2198, 2005.
DOI : 10.1128/JVI.79.4.2191-2198.2005

M. L. Perdue, D. L. Suarez, R. K. Van, and M. Pensaert, Structural features of the avian influenza virus hemagglutinin that influence virulence, Veterinary Microbiology, vol.74, issue.1-2, pp.77-86, 2000.
DOI : 10.1016/S0378-1135(00)00168-1

M. Hatta, G. A. Peng, P. Halfmann, and Y. Kawaoka, Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses, Science, vol.293, issue.5536, pp.1840-1842, 2001.
DOI : 10.1126/science.1062882

D. J. Hulse, R. G. Webster, R. J. Russell, and D. R. Perez, Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens, Journal of Virology, vol.78, issue.18, pp.9954-9964, 2004.
DOI : 10.1128/JVI.78.18.9954-9964.2004

S. J. Baigent and J. W. Mccauley, Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture, Virus Research, vol.79, issue.1-2, pp.177-185, 2001.
DOI : 10.1016/S0168-1702(01)00272-6

K. Shinya, S. Hamm, M. Hatta, H. Ito, T. Ito et al., PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice, Virology, vol.320, issue.2, pp.258-266, 2004.
DOI : 10.1016/j.virol.2003.11.030

S. H. Seo, E. Hoffmann, and R. G. Webster, RETRACTED: The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses, Virus Research, vol.103, issue.1-2, pp.107-113, 2004.
DOI : 10.1016/j.virusres.2004.02.022

A. S. Lipatov, S. Andreansky, R. J. Webby, D. J. Hulse, J. E. Rehg et al., Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses, Journal of General Virology, vol.86, issue.4, pp.1121-1130, 2005.
DOI : 10.1099/vir.0.80663-0

C. Y. Cheung, L. L. Poon, A. S. Lau, W. Luk, Y. L. Lau et al., Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?, The Lancet, vol.360, issue.9348, pp.1831-1837, 2002.
DOI : 10.1016/S0140-6736(02)11772-7

D. L. Noah and R. M. Krug, Influenza Virus Virulence and Its Molecular Determinants, Adv Virus Res, vol.65, pp.121-145, 2005.
DOI : 10.1016/S0065-3527(05)65004-X

Y. Abed, I. Hardy, Y. Li, and G. Boivin, Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada, Journal of Medical Virology, vol.224, issue.4, pp.589-595, 2002.
DOI : 10.1006/viro.1996.0519

D. W. Van and J. C. Manuguerra, Bases moléculaires de la variabilité et diffusion des virus grippaux. (Molecular basis of influenza virus variability and diffusion), 2000.

D. E. Stallkenecht and S. M. Shane, Host range of avian influenza virus in free-living birds, Veterinary Research Communications, vol.3, issue.1, pp.125-141, 1988.
DOI : 10.7883/yoken1952.31.407

D. J. Alexander, A review of avian influenza in different bird species, Veterinary Microbiology, vol.74, issue.1-2, pp.3-13, 2000.
DOI : 10.1016/S0378-1135(00)00160-7

D. J. Alexander, The epidemiology and control of avian influenza and Newcastle disease, Journal of Comparative Pathology, vol.112, issue.2, pp.105-126, 1995.
DOI : 10.1016/S0021-9975(05)80054-4

D. T. Cappucci, . Jr, D. C. Johnson, M. Brugh, T. M. Smith et al., Isolation of Avian Influenza Virus (Subtype H5N2) from Chicken Eggs during a Natural Outbreak, Avian Diseases, vol.29, issue.4, pp.1195-1200, 1985.
DOI : 10.2307/1590473

B. C. Easterday, V. S. Hinshaw, and D. A. Halvorson, Influenza, pp.583-605, 1997.

E. C. Claas, J. J. De, B. R. Van, G. F. Rimmelzwaan, and A. D. Osterhaus, Human influenza virus A/HongKong, H5N1) infection, pp.977-978, 1998.

R. A. Bright, D. S. Cho, T. Rowe, and J. M. Katz, Mechanisms of Pathogenicity of Influenza A (H5N1) Viruses in Mice, Avian Diseases, vol.47, issue.s3, pp.1131-1134, 2003.
DOI : 10.1637/0005-2086-47.s3.1131

Y. K. Choi, T. D. Nguyen, H. Ozaki, R. J. Webby, P. Puthavathana et al., Studies of H5N1 Influenza Virus Infection of Pigs by Using Viruses Isolated in Vietnam and Thailand in 2004, Journal of Virology, vol.79, issue.16, pp.10821-10825, 2005.
DOI : 10.1128/JVI.79.16.10821-10825.2005

E. Hoffmann, Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004, J Virol, vol.79, pp.2191-2198, 2005.

M. Quirk, Zoo tigers succumb to avian influenza, The Lancet Infectious Diseases, vol.4, issue.12, p.716, 2004.
DOI : 10.1016/S1473-3099(04)01216-2

W. H. Allan and R. E. Gough, A standard haemagglutination inhibition test for Newcastle disease. (1). A comparison of macro and micro methods, Veterinary Record, vol.95, issue.6, pp.120-123, 1974.
DOI : 10.1136/vr.95.6.120

C. W. Beard, Demonstration of type specific influenza antibody in mammalian and avian serum by immunodiffusion, Bull. World Health Organ, vol.42, pp.779-785, 1970.

I. Capua and S. Marangaon, La vaccination en tant qu'outil utilisable contre l'influenza aviaire, Organisation Mondiale de la Santé animale. 71 ème session générale du Comité International, pp.18-23, 2003.

D. E. Swayne and D. L. Suarez, Highly pathogenic avian influenza, Revue Scientifique et Technique de l'OIE, vol.19, issue.2, pp.463-482, 2000.
DOI : 10.20506/rst.19.2.1230

URL : https://hal.archives-ouvertes.fr/hal-01290641

I. Capua, S. Maragon, D. Pozza, M. Santucci, and U. , Vaccination for avian influenza in Italy, Vet. Rec, vol.147, p.751, 2000.

C. W. Beard, W. M. Schnitzlein, and D. N. Tripathy, Protection of Chickens against Highly Pathogenic Avian Influenza Virus (H5N2) by Recombinant Fowlpox Viruses, Avian Diseases, vol.35, issue.2, 1991.
DOI : 10.2307/1591189

C. W. Beard, W. M. Schnitzlein, and D. N. Tripathy, Effect of Route of Administration on the Efficacy of a Recombinant Fowlpox Virus against H5N2 Avian Influenza, Avian Diseases, vol.36, issue.4, pp.1052-1055, 1992.
DOI : 10.2307/1591573

D. E. Swayne, J. R. Beck, and T. R. Mickle, Efficacy of Recombinant Fowl Poxvirus Vaccine in Protecting Chickens against a Highly Pathogenic Mexican-Origin H5N2 Avian Influenza Virus, Avian Diseases, vol.41, issue.4, pp.910-922, 1997.
DOI : 10.2307/1592346

D. E. Swayne, M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez, Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, vol.18, issue.11-12, pp.1088-1095, 2000.
DOI : 10.1016/S0264-410X(99)00369-2

R. G. Webster, J. Taylor, J. E. Pearson, E. Rivera, and E. Paoletti, Immunity to Mexican H5N2 Avian Influenza Viruses Induced by a Fowl Pox-H5 Recombinant, Avian Diseases, vol.40, issue.2, pp.461-465, 1996.
DOI : 10.2307/1592246

D. Luschow, O. Werner, T. C. Mettenleiter, and W. Fuchs, Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene, Vaccine, vol.19, issue.30, pp.4249-4259, 2001.
DOI : 10.1016/S0264-410X(01)00167-0

S. Maragon, L. Bortolotti, I. Capua, M. Bettio, D. Pozza et al., Lowpathogenicity avian influenza (LPAI) in Italy (2002-01): epidemiology and control, 2003.

D. Jong, M. D. Hien, and T. T. , Avian influenza A(H5N1), J Clin Virol, vol.35, pp.2-13, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00589027

K. Y. Yuen and S. S. Wong, Human infection by avian influenza AH5N1, Hong Kong Med J, vol.11, pp.189-199, 2005.

C. Grose and K. Chokephaibulkit, Avian Influenza Virus Infection of Children in Vietnam and Thailand, The Pediatric Infectious Disease Journal, vol.23, issue.8, pp.793-794, 2004.
DOI : 10.1097/00006454-200408000-00024

P. K. Chan, Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997, Clinical Infectious Diseases, vol.354, issue.Suppl, pp.58-64, 2002.
DOI : 10.1016/S0140-6736(99)03311-5

K. Chokephaibulkit, M. Uiprasertkul, P. Puthavathana, P. Chearskul, P. Auewarakul et al., A Child With Avian Influenza A (H5N1) Infection, The Pediatric Infectious Disease Journal, vol.24, issue.2, 2005.
DOI : 10.1097/01.inf.0000151037.25237.1e

J. H. Beigel, J. Farrar, A. M. Han, F. G. Hayden, R. Hyer et al., Avian influenza A(H5N1) infection in humans, N Engl J Med, vol.353, pp.1374-1385, 2005.

A. Apisarnthanarak, R. Kitphati, K. Thongphubeth, P. Patoomanunt, P. Anthanont et al., Atypical avian influenza (H5N1), Emerg Infect Dis, vol.10, pp.1321-1324, 2004.

V. Wiwanitkit, Diarrhoea as a presentation of bird flu infection: a summary on its correlation to outcome in Thai cases, Gut, vol.54, issue.10, p.1506, 2005.
DOI : 10.1136/gut.2005.072488

D. Jong, M. D. Bach, V. C. Phan, T. Q. Vo, M. H. Tran et al., Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma, New England Journal of Medicine, vol.352, issue.7, pp.686-691, 2005.
DOI : 10.1056/NEJMoa044307

J. M. Katz, W. Lim, C. B. Bridges, T. Rowe, J. Hu-primmer et al., Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti???H5 Antibody among Household and Social Contacts, The Journal of Infectious Diseases, vol.180, issue.6, pp.1763-1770, 1999.
DOI : 10.1086/315137

C. B. Bridges, J. M. Katz, W. H. Seto, P. K. Chan, D. Tsang et al., Risk of Influenza A (H5N1) Infection among Health Care Workers Exposed to Patients with Influenza A (H5N1), Hong Kong, The Journal of Infectious Diseases, vol.181, issue.1, pp.344-348, 2000.
DOI : 10.1086/315213

C. B. Bridges, W. Lim, J. Hu-primmer, L. Sims, K. Fukuda et al., Risk of Influenza A (H5N1) Infection among Poultry Workers, Hong Kong, 1997???1998, The Journal of Infectious Diseases, vol.185, issue.8, pp.1005-1010, 1997.
DOI : 10.1086/340044

V. Demicheli, T. Jefferson, D. Rivetti, and J. Deeks, Prevention and early treatment of influenza in healthy adults, Vaccine, vol.18, issue.11-12, pp.957-1030, 2000.
DOI : 10.1016/S0264-410X(99)00332-1

M. P. Girard, T. Cherian, Y. Pervikov, and M. P. Kieny, A review of vaccine research and development: Human acute respiratory infections, Vaccine, vol.23, issue.50, pp.5708-5724, 2005.
DOI : 10.1016/j.vaccine.2005.07.046

D. Clercq, E. Neyts, and J. , Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention, Trends in Pharmacological Sciences, vol.28, issue.6, pp.280-285, 2007.
DOI : 10.1016/j.tips.2007.04.005

J. Beigel and M. Bray, Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Research, vol.78, issue.1, pp.91-102, 2008.
DOI : 10.1016/j.antiviral.2008.01.003

G. Zoidis, C. Fytas, I. Papanastasiou, G. B. Foscolos, G. Fytas et al., Heterocyclic rimantadine analogues with antiviral activity, Bioorganic & Medicinal Chemistry, vol.14, issue.10, pp.3341-3348, 2006.
DOI : 10.1016/j.bmc.2005.12.056

H. J. Schunemann, S. R. Hill, M. Kadad, R. Bellamy, T. M. Uyeki et al., WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus, The Lancet Infectious Diseases, vol.7, issue.1, pp.21-31, 2007.
DOI : 10.1016/S1473-3099(06)70684-3

R. W. Sidwell, J. H. Huffman, G. P. Khare, L. B. Allen, J. T. Witkowski et al., Broad-spectrum antiviral activity of virazole: 1-?-D-ribofuranosyl-1, Science, vol.2, issue.177, pp.4-7, 1972.

P. Leyssen, E. De-clercq, and J. Neyts, Molecular strategies to inhibit the replication of RNA viruses, Antiviral Research, vol.78, issue.1, pp.9-25, 2008.
DOI : 10.1016/j.antiviral.2008.01.004

C. B. Smith, R. P. Charette, J. P. Fox, M. K. Cooney, and C. E. Hall, Lack of Effect of Oral Ribavirin in Naturally Occurring Influenza A Virus (H1N1) Infection, Journal of Infectious Diseases, vol.141, issue.5, pp.548-554, 1980.
DOI : 10.1093/infdis/141.5.548

D. S. Stein, C. M. Creticos, G. G. Jackson, J. M. Bernstein, F. G. Hayden et al., Oral ribavirin treatment of influenza A and B., Antimicrobial Agents and Chemotherapy, vol.31, issue.8, 1987.
DOI : 10.1128/AAC.31.8.1285

R. W. Sidwell, K. W. Bailey, M. H. Wong, D. L. Barnard, and D. F. Smee, In vitro and in vivo influenza virus-inhibitory effects of viramidine, Antiviral Research, vol.68, issue.1, pp.10-17, 2005.
DOI : 10.1016/j.antiviral.2005.06.003

Y. Furuta, K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama et al., In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, vol.46, issue.4, pp.977-981, 2002.
DOI : 10.1128/AAC.46.4.977-981.2002

Y. Furuta, K. Takahashi, M. Kuno-maekawa, H. Sangawa, S. Uehara et al., Mechanism of Action of T-705 against Influenza Virus, Antimicrobial Agents and Chemotherapy, vol.49, issue.3, pp.981-986, 2005.
DOI : 10.1128/AAC.49.3.981-986.2005

B. B. Gowen, M. H. Wong, K. H. Jung, A. B. Sanders, M. Mendenhall et al., In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections, vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections, pp.3168-3176, 2007.
DOI : 10.1128/AAC.00356-07

R. W. Sidwell, D. L. Barnard, C. W. Day, D. F. Smee, K. W. Bailey et al., Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.845-851, 2007.
DOI : 10.1128/AAC.01051-06

K. Takahashi, Y. Furuta, Y. Fukuda, M. Kuno, T. Kamiyama et al., Activities of T-705 and Oseltamivir against Influenza Virus, Antiviral Chemistry and Chemotherapy, vol.67, issue.5, pp.235-241, 2003.
DOI : 10.1016/S0166-3542(01)00124-3

Q. Ge, L. Filip, A. Bai, T. Nguyen, H. N. Eisen et al., Inhibition of influenza virus production in virus-infected mice by RNA interference, Proc. Natl. Acad. Sci, 2004.
DOI : 10.3201/eid0805.010476

Q. Ge, M. Pastey, D. Kobasa, P. Puthavathana, C. Lupfer et al., Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers, Antimicrobial Agents and Chemotherapy, vol.50, issue.11, pp.3724-3733, 2006.
DOI : 10.1128/AAC.00644-06

K. F. To, P. K. Chan, K. F. Chan, W. K. Lee, W. Y. Lam et al., Pathology of fatal human infection associated with avian influenza A H5N1 virus, Journal of Medical Virology, vol.351, issue.3, pp.242-246, 2001.
DOI : 10.1016/S0140-6736(98)01182-9

Y. Wu, G. Zhang, Y. Li, Y. Jin, R. Dale et al., Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene, Biochemical and Biophysical Research Communications, vol.365, issue.2, pp.369-374, 2008.
DOI : 10.1016/j.bbrc.2007.10.196

H. and A. Kong, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A, Antiviral research, vol.1569799, issue.48, pp.101-115, 1074.

T. Suzuki, Y. Suzuki, and Y. Kawaoka, Avian flu: isolation of drug-resistant H5N1 virus, Nature, vol.437, pp.1108-139, 2005.

P. Ward, The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies, Drug Metab. Dispos, vol.30, pp.13-19, 2002.

H. L. Yen, A. S. Monto, R. G. Webster, and E. A. Govorkova, Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice, The Journal of Infectious Diseases, vol.192, issue.4, pp.665-672, 2005.
DOI : 10.1086/432008

J. L. Breschkin and P. M. Colman, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, 1998.

K. W. Feng, W. C. Babu, Y. S. Bush, and K. , Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of, 2001.

W. M. Kati, D. Montgomery, R. Carrick, L. Gubareva, C. Maring et al., In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, vol.46, issue.4, pp.1014-1021, 2002.
DOI : 10.1128/AAC.46.4.1014-1021.2002

V. P. Mishin, F. G. Hayden, and L. V. Gubareva, Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4515-4520, 2005.
DOI : 10.1128/AAC.49.11.4515-4520.2005

S. Tsiodras, J. D. Mooney, and A. Hatzakis, Role of combination antiviral therapy in pandemic influenza and stockpiling implications, BMJ, vol.334, issue.7588, pp.293-294, 2007.
DOI : 10.1136/bmj.39105.428981.BE

M. Elliott, H. L. Weiss, and F. G. Hayden, Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza, Antivir. Ther, vol.8, pp.183-190, 2003.

A. Meijer, M. Valette, J. C. Manuguerra, P. Perez-brena, J. Paget et al., Implementation of the Community Network of Reference Laboratories for Human Influenza in Europe, Journal of Clinical Virology, vol.34, issue.2, pp.87-96, 2005.
DOI : 10.1016/j.jcv.2005.02.005

B. J. Fenner, L. Spencer, and J. Kwang, Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture, BMC Microbiol, vol.6, pp.16-141, 2006.

M. O. Delia, J. I. Yaying, L. Woods, S. Hietala, and M. Bryant, Recombinant influenza A virus vaccines for the pathogenic human A, H5N1) viruses, pp.1132-1138, 1999.

X. Lu, J. Katz, N. Cox, and Y. Matsuoka, Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics, Virology, vol.305, pp.192-200, 2003.

T. Odagiri, M. Tashiro, W. Lim, Y. Guan, M. Peiris et al., The development and characterization of H5 influenza virus, 2003.

M. C. Zambon, Safety and antigenicity of non-adjuvanted and MF59- adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza, Lancet, issue.9272, pp.357-1937, 2001.

O. 'brien, D. Wolff, M. Rabinovich, G. Blackwelder, W. Katz et al., Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans, 2001.

K. Mcclellan and C. M. Perry, Oseltamivir, Drugs, vol.171, issue.9, pp.263-283, 2001.
DOI : 10.2165/00003495-200161020-00011

I. R. Mcnicholl and J. J. Mcnicholl, Neuraminidase inhibitors : Zanamivir and oseltamivir. (The) Annals of pharmacotherapy, pp.57-70, 2001.

P. Ward, I. Small, J. Smith, P. Suter, and R. Dutkowski, Oseltamivir (Tamiflu??) and its potential for use in the event of an influenza pandemic, Journal of Antimicrobial Chemotherapy, vol.55, issue.suppl_1, pp.5-21, 2005.
DOI : 10.1093/jac/dki018

T. Suzuki, Y. Suzuki, and Y. Kawaoka, Avian flu: isolation of drug-resistant H5N1 virus, Nature, vol.437, p.1108, 2005.

J. Blancou, La longue histoire des pestes aviaires, In : Site de l'Académie vétérinaire de France, 2007.

T. Delvallée, Actualités sur la grippe aviaire et sa transmission chez l'homme In : Site du CNRS et de l'INIST, la grippe aviaire et l'homme, le dossier de synthèse, 2006.

J. Guerin, Dossier d'actualité : ce qu'il faut savoir sur l'influenza aviaire ou grippe aviaire In : Site de l'Ecole Nationale Vétérinaire de Toulouse, 2006.

O. Mondiale-de and L. Santé, Grippe aviaire : questions fréquemment posées In : Site de l'OMS, 2005.

O. Mondiale-de and L. Santé, Areas reported confirmed occurrence of H5N1 avian influenza in poultry and wild birds since, 2003.

O. Mondiale-de and L. Santé, Comment faire face à la menace d'une pandémie de grippe aviaire. Mesures stratégiques recommandées, 2005.

L. Ministère-de and . Santé, Grippe saisonnière :prévention des épidémies et du risque nosocomial, 2008.

. Ministère-de-l-'agriculture-et-de-la-pêche, Notion d'information sur le dispositif de surveillance et de prévention de l'influenza aviaire chez les oiseaux captifs, retenu pour l'automne et l'hiver des années, 2006.

. La, ou grippe du poulet ou influenza aviaire) : risques infectieux en milieu de soins, Site du Ministère de la Santé, 2008.

H. L. Didier, indispensable préparation à une pandémie. Les Nouvelles Pharmaceutiques, n°309, 1 er décembre, 2005.

. Ministère-de-l-'agriculture-et-de-la-pêche, Influenza aviaire : protection des éleveurs et professionnels au contact avec des volailles vivantes, 2006.

. Ministère-de-l-'ecologie and . Du-développement-durable, Grippe aviaire et oiseaux des villes et des campagnes : face à la grippe aviaire vis-à-vis des oiseaux sauvages, 2008.

O. Mondiale-de and L. Santé, Les volailles et oeufs bien cuits ne présentent aucun risque de grippe aviaire pour le consommateur, 2005.

. Site-de-l-'oie, Organisation Mondiale de la Santé animale) Code sanitaire pour la santé des animaux terrestres. Chapitre 4.13 : élimination des carcasses

. Site-de-l-'oie, Organisation Mondiale de la Santé animale) Code sanitaire pour la santé des animaux terrestres. Chapitre 7.6 : mise à mort d'animaux à des fins prophylactiques, 2009.